tiprankstipranks
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Income Statement

Compare
0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Income Statement

Last quarter (Q1 2024), ASKA Pharmaceutical Holdings Co., Ltd.'s total revenue was ¥16.35B, an increase of 2.05% from the same quarter last year. In Q1, ASKA Pharmaceutical Holdings Co., Ltd.'s net income was ¥1.27B. See ASKA Pharmaceutical Holdings Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 62.84B¥ 60.46B¥ 56.61B¥ 55.18B¥ 52.54B
Gross Profit
¥ 30.66B¥ 28.59B¥ 26.35B¥ 25.38B¥ 24.02B
Operating Expenses
¥ 24.16B¥ 23.48B¥ 21.56B¥ 21.77B¥ 22.51B
Depreciation and Amortization
¥ 2.66B¥ 3.13B¥ 2.88B¥ 3.36B¥ 3.76B
EBITDA
¥ 12.57B¥ 8.24B¥ 7.68B¥ 6.97B¥ 5.27B
Operating Income
¥ 6.50B¥ 5.11B¥ 4.79B¥ 3.61B¥ 1.51B
Other Income/Expenses
¥ 3.36B¥ 249.00M¥ 1.37B¥ -35.00M¥ -607.00M
Pretax Income
¥ 9.86B¥ 5.36B¥ 6.16B¥ 3.58B¥ 901.00M
Net Income
¥ 7.54B¥ 4.24B¥ 4.29B¥ 2.71B¥ 649.00M
Per Share Metrics
Basic EPS
¥ 266.49¥ 150.08¥ 151.22¥ 95.63¥ 22.94
Diluted EPS
¥ 266.49¥ 150.08¥ 151.22¥ 95.63¥ 22.94
Weighted Average Shares Outstanding
28.31M 28.24M 28.37M 28.37M 28.29M
Weighted Average Shares Outstanding (Diluted)
28.31M 28.24M 28.37M 28.37M 28.29M
Currency in JPY

ASKA Pharmaceutical Holdings Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis